However, PD-L1 is also extensively detected in TME, and tumor cells smartly hijack this negative regulatory PD-1/PD-L1 pathway for immune evasion through the exhaustion and apoptosis of the infiltrating effector T cells (Figure 1B). Here, PDCD1 is linked to neoplasm.